Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-156654
Filing Date
2025-07-08
Accepted
2025-07-08 17:14:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d73794d424b5.htm 424B5 442901
2 GRAPHIC g73794g71u78.jpg GRAPHIC 70048
3 GRAPHIC g73794g99p03.jpg GRAPHIC 51694
  Complete submission text file 0001193125-25-156654.txt   607234
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269707 | Film No.: 251111695
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)